BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26107189)

  • 21. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.
    Zhou D; Cantu C; Sagiv Y; Schrantz N; Kulkarni AB; Qi X; Mahuran DJ; Morales CR; Grabowski GA; Benlagha K; Savage P; Bendelac A; Teyton L
    Science; 2004 Jan; 303(5657):523-7. PubMed ID: 14684827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer.
    Bai L; Sagiv Y; Liu Y; Freigang S; Yu KO; Teyton L; Porcelli SA; Savage PB; Bendelac A
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10254-9. PubMed ID: 19506241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells.
    Bedard M; Shrestha D; Priestman DA; Wang Y; Schneider F; Matute JD; Iyer SS; Gileadi U; Prota G; Kandasamy M; Veerapen N; Besra G; Fritzsche M; Zeissig S; Shevchenko A; Christianson JC; Platt FM; Eggeling C; Blumberg RS; Salio M; Cerundolo V
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23671-23681. PubMed ID: 31690657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid metabolism, atherogenesis and CD1-restricted antigen presentation.
    Major AS; Joyce S; Van Kaer L
    Trends Mol Med; 2006 Jun; 12(6):270-8. PubMed ID: 16651026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism.
    Schümann J; Facciotti F; Panza L; Michieletti M; Compostella F; Collmann A; Mori L; De Libero G
    Eur J Immunol; 2007 Jun; 37(6):1431-41. PubMed ID: 17492806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gel Phase 1,2-Distearoyl-
    Norling K; Bernasconi V; Agmo Hernández V; Parveen N; Edwards K; Lycke NY; Höök F; Bally M
    ACS Infect Dis; 2019 Nov; 5(11):1867-1878. PubMed ID: 31498993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens.
    Gao J; Ochyl LJ; Yang E; Moon JJ
    Int J Nanomedicine; 2017; 12():1251-1264. PubMed ID: 28243087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The crystal structure of human CD1d with and without alpha-galactosylceramide.
    Koch M; Stronge VS; Shepherd D; Gadola SD; Mathew B; Ritter G; Fersht AR; Besra GS; Schmidt RR; Jones EY; Cerundolo V
    Nat Immunol; 2005 Aug; 6(8):819-26. PubMed ID: 16007090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.
    Hussain MJ; Wilkinson A; Bramwell VW; Christensen D; Perrie Y
    J Pharm Pharmacol; 2014 Mar; 66(3):358-66. PubMed ID: 24251796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
    Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
    Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages.
    Tanaka Y; Kasai M; Taneichi M; Naito S; Kato H; Mori M; Nishida M; Maekawa N; Yamamura H; Komuro K; Uchida T
    Bioconjug Chem; 2004; 15(1):35-40. PubMed ID: 14733581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An increased adjuvanticity of liposomes by the inclusion of phosphatidylserine in immunization with surface-coupled liposomal antigen.
    Mori M; Nishida M; Maekawa N; Yamamura H; Tanaka Y; Kasai M; Taneichi M; Uchida T
    Int Arch Allergy Immunol; 2005 Jan; 136(1):83-9. PubMed ID: 15591816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach.
    Soema PC; Willems GJ; Jiskoot W; Amorij JP; Kersten GF
    Eur J Pharm Biopharm; 2015 Aug; 94():427-35. PubMed ID: 26144666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunological functions of saposins.
    Darmoise A; Maschmeyer P; Winau F
    Adv Immunol; 2010; 105():25-62. PubMed ID: 20510729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycolipid antigen processing for presentation by CD1d molecules.
    Prigozy TI; Naidenko O; Qasba P; Elewaut D; Brossay L; Khurana A; Natori T; Koezuka Y; Kulkarni A; Kronenberg M
    Science; 2001 Jan; 291(5504):664-7. PubMed ID: 11158680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis.
    Iyer AK; Liu J; Gallo RM; Kaplan MH; Brutkiewicz RR
    Immunology; 2015 Nov; 146(3):444-55. PubMed ID: 26260288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.
    Schneiders FL; Huijts CM; Mantici A; Menks MA; Scotet E; Veerhuis R; Verheul HM; de Gruijl TD; van der Vliet HJ
    Clin Immunol; 2015 May; 158(1):92-9. PubMed ID: 25796193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells.
    Kaur R; Chen J; Dawoodji A; Cerundolo V; Garcia-Diaz YR; Wojno J; Cox LR; Besra GS; Moghaddam B; Perrie Y
    J Pharm Sci; 2011 Jul; 100(7):2724-33. PubMed ID: 21283989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.